Holen Sie sich die Stockscreener-App
118.07
2.00%
2.32
Vorhandelsmarkt:
118.00
-0.07
-0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ZTS?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$115.75
Offen:
$115.96
24-Stunden-Volumen:
5.90M
Relative Volume:
1.51
Marktkapitalisierung:
$52.03B
Einnahmen:
$9.40B
Nettoeinkommen (Verlust:
$2.65B
KGV:
19.89
EPS:
5.935
Netto-Cashflow:
$2.24B
1W Leistung:
-3.67%
1M Leistung:
-1.44%
6M Leistung:
-29.34%
1J Leistung:
-33.18%
1-Tages-Spanne:
$115.60
$118.44
1-Wochen-Bereich:
$115.59
$123.31
52-Wochen-Spanne:
$115.25
$181.85
Zoetis Inc Stock (ZTS) Company Profile
Firmenname
Zoetis Inc
Sektor
Telefon
973-822-7000
Adresse
10 SYLVAN WAY, PARSIPPANY, NJ
Vergleichen Sie ZTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-12 | Bestätigt | Stifel | Buy |
| 2023-12-19 | Fortgesetzt | Jefferies | Buy |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-03-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-08-14 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-08-12 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-05-27 | Eingeleitet | Jefferies | Buy |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-09-09 | Eingeleitet | Goldman | Buy |
| 2019-07-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2019-05-03 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-03-04 | Hochstufung | Stifel | Hold → Buy |
| 2019-01-23 | Eingeleitet | UBS | Neutral |
| 2018-10-15 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-22 | Herabstufung | Stifel | Buy → Hold |
| 2018-08-03 | Bestätigt | Stifel | Buy |
| 2018-04-19 | Bestätigt | Citigroup | Buy |
| 2018-03-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | Bestätigt | Stifel | Buy |
| 2018-01-04 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Zoetis Inc Aktie (ZTS) Neueste Nachrichten
Zoetis Inc ZOE Stock Analysis and ForecastHigh Beta Stocks & Outstanding Return Portfolio - earlytimes.in
HSBC Adjusts Zoetis Price Target to $140 From $180, Maintains Buy Rating - marketscreener.com
Zoetis (ZTS) Receives 'Equal-Weight' Rating from Barclays with a $136 Target | ZTS Stock News - GuruFocus
Zoetis Inc's (ZTS) Innovation Engine Remains Robust, Say's William Blair - Finviz
Zoetis Inc’s (ZTS) Innovation Engine Remains Robust, Say’s William Blair - Insider Monkey
Zoetis Inc. $ZTS Stock Position Lowered by Fayez Sarofim & Co - MarketBeat
Axa S.A. Sells 294,654 Shares of Zoetis Inc. $ZTS - MarketBeat
A New Veterinary Approval Offers Hope for Zoetis Investors - AD HOC NEWS
What's Driving the Market Sentiment Around Zoetis Inc? - Benzinga
Jump Financial LLC Sells 59,951 Shares of Zoetis Inc. $ZTS - MarketBeat
Cerity Partners LLC Increases Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
California Public Employees Retirement System Cuts Stock Position in Zoetis Inc. $ZTS - MarketBeat
First Trust Advisors LP Trims Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Animal Vaccines Market Top key Players 2035 | Vetoquinol, Heska - openPR.com
Edgestream Partners L.P. Has $1.73 Million Stake in Zoetis Inc. $ZTS - MarketBeat
Amundi Has $439.04 Million Stake in Zoetis Inc. $ZTS - MarketBeat
1832 Asset Management L.P. Acquires 9,472 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis (NYSE:ZTS) Shares Unloaded Sen. Markwayne Mullin - MarketBeat
Zoetis Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zoetis (ZTS) Gains Health Canada Approval for New Cat Osteoarthritis Treatment - GuruFocus
EBIT per share of Zoetis, Inc. Class A – GETTEX:ZOE - TradingView
Zoetis Says Health Canada Approves Long-Lasting Cat Osteoarthritis Drug - marketscreener.com
Zoetis receives Health Canada approval for feline arthritis therapy By Investing.com - Investing.com Australia
Zoetis receives Health Canada approval for feline arthritis therapy - Investing.com
Earnings are growing at Zoetis (NYSE:ZTS) but shareholders still don't like its prospects - Yahoo Finance
Zoetis receives Health Canada approval for Portela (Relfovetmab injection) - marketscreener.com
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats - Bakersfield.com
(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats - Business Wire
Invesco Ltd. Buys 468,173 Shares of Zoetis Inc. $ZTS - MarketBeat
Is Zoetis Inc. (ZOE) stock bottoming after sell offEarnings Recap Summary & Entry Point Confirmation Signals - Newser
Panagora Asset Management Inc. Sells 8,834 Shares of Zoetis Inc. $ZTS - MarketBeat
Why Zoetis Inc. (ZOE) stock stays on top picksJuly 2025 EndofMonth & Risk Controlled Stock Alerts - Newser
Epoch Investment Partners Inc. Sells 187,530 Shares of Zoetis Inc. $ZTS - MarketBeat
Brown Advisory Inc. Purchases 250,829 Shares of Zoetis Inc. $ZTS - MarketBeat
Baird Financial Group Inc. Decreases Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Is Zoetis Inc. Class stock a momentum leaderPortfolio Return Report & Fast Gain Swing Trade Alerts - Newser
Zoetis Inc. (NYSE:ZTS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Is Zoetis Inc. (ZOE) stock a buy before earnings resultsOil Prices & Weekly Watchlist for Consistent Profits - Newser
Zoetis Stock Plummets 24.8% YTD: Here's What You Need to Know - sharewise.com
Zoetis (ZTS) Up 1.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Transcript : Zoetis Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-04-2025 09 - marketscreener.com
Zoetis Inc. (ZTS): A bull case theory - MSN
Zoetis Inc. (ZTS): A Bull Case Theory - Insider Monkey
BTIG Research Reiterates "Buy" Rating for Zoetis (NYSE:ZTS) - MarketBeat
Schroder Investment Management Group Decreases Holdings in Zoetis Inc. $ZTS - MarketBeat
Quantbot Technologies LP Sells 25,551 Shares of Zoetis Inc. $ZTS - MarketBeat
Why Zoetis Inc. Class stock is a strong analyst pick2025 Price Targets & AI Driven Stock Movement Reports - Newser
Zoetis Inc. $ZTS Shares Bought by Guggenheim Capital LLC - MarketBeat
Zoetis Hosts Innovation Webcast on Animal Health - MSN
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
TD Cowen Adjusts Zoetis Price Target to $150 From $189, Maintains Buy Rating - marketscreener.com
Finanzdaten der Zoetis Inc-Aktie (ZTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):